Pfizer Monthly Outlook (March 2026) | Price, Target Price & Growth

Pfizer

NSEI:PFIZER

Rp 4.709,50

Rp0,00 (0,00%)

4.709,50 Rp

Rp0,00 (0,00%)

End-of-day quote: 03/27/2026

Pfizer Stock Value

Currently, analysts rate Pfizer as Outperform.

Outperform

Pfizer Company Info

EPS Growth 5Y

4,16%

Market Cap

Rp215,45 B

Long-Term Debt

Rp0,03 B

Annual earnings

05/19/2026 (E)

Dividend

Rp34,85

Dividend Yield

0,74%

Founded

1950

Industry

Health Care

Country

India

Website

Pfizer

ISIN Number

INE182A01018

Website

http://www.pfizerltd.co.in

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Rp6.375,00

35.36%

Last Update: 03/28/2026

Analysts: 3

Highest Price Target Rp7.500,00

Average Price Target Rp6.375,00

Lowest Price Target Rp6.100,00

In the last five quarters, Pfizer’s Price Target has risen from Rp5.012,33 to Rp5.623,33 - a 12,19% increase. Two analysts predict that Pfizer’s share price will increase in the coming year, reaching Rp6.375,00. This would represent an increase of 35,36%.

Top growth stocks in the health care sector (5Y.)

What does Pfizer do?

Pfizer Limited, a subsidiary of Pfizer Inc., operates in the pharmaceutical sector, focusing on the research, development, manufacturing, and distribution of a wide range of medications and vaccines. Business Segments The company operates through development, manufacturing, and marketing of innovative Pharmaceutical Products, Vaccines, and Consumer Healthcare Products segments. The key therapeutic areas include oncology, cardiology, immunology, and rare diseases, which allow the company to cat...

Pfizer Limited, a subsidiary of Pfizer Inc., operates in the pharmaceutical sector, focusing on the research, development, manufacturing, and distribution of a wide range of medications and vaccines.

Business Segments

The company operates through development, manufacturing, and marketing of innovative Pharmaceutical Products, Vaccines, and Consumer Healthcare Products segments. The key therapeutic areas include oncology, cardiology, immunology, and rare diseases, which allow the company to cater to a diverse patient base with varying medical needs.

Pharmaceutical

This segment is the backbone of the company’s operations, where it focuses on pioneering new treatments and drugs that address unmet medical needs. Within this segment, the company conducts extensive research and development to ensure the efficacy and safety of its drug candidates. Advanced clinical trials are implemented to support the launch of these products into various markets.

Vaccines

This segment is particularly given the rising global health concerns to which immunization can respond effectively. The company's vaccine portfolio includes products to combat prevalent diseases, contributing significantly to public health efforts both domestically and internationally.

Consumer Healthcare Products

This segment encompasses over-the-counter products that promote wellness. This range of products is designed to cater to everyday health needs, ensuring a comprehensive approach to patient care that extends beyond prescription medications.

Business Strategy

The company’s business strategy is rooted in its commitment to innovation and accountability towards stakeholders. The company places significant emphasis on research and development, channeling resources into discovering groundbreaking therapies and ensuring a robust pipeline of innovative products. Strategic investments in R&D are pivotal for fostering advancements that align with the company's mission of addressing critical healthcare challenges.

Further, the company prioritizes compliance with regulatory standards, ensuring all its operations adhere meticulously to the rules and guidelines laid down by health authorities. This commitment to compliance safeguards not only the company’s reputation but also reflects its dedication to fostering trust among consumers and stakeholders.

Market expansion represents another critical element of the company's strategy. The company continuously seeks opportunities to penetrate new markets and bolster its presence in existing markets by tailoring its product offerings to meet local consumer health needs. This geographic diversification enhances resilience against market fluctuations while capturing growth opportunities across different regions.

Additionally, based on the insights derived from market research, the company is vigilant in tracking market trends and the competitive landscape. This approach enables the company to adapt to shifts in consumer preferences and align its strategies accordingly. By staying attuned to customer needs and preferences, the company can position its products effectively within the marketplace, enhancing brand loyalty and fostering lasting relationships with consumers.

Products and Services

The company provides a wide array of products and services tailored to meet the diverse needs of its consumers. The core of its offerings is rooted in innovative pharmaceutical products that address a range of medical conditions. These products are developed through extensive research backed by science and clinical evidence, ensuring that they adhere to the highest standards of quality and efficacy.

In the realm of oncology, the company offers a selection of targeted therapies designed to combat various types of cancer. The company invests heavily in the development of personalized medicine that equips healthcare providers with the necessary tools to tailor treatment options to individual patient profiles.

The immunology segment features therapies that target autoimmune diseases, offering relief and treatment options to patients suffering from chronic conditions. These products have been subject to rigorous research and clinical trials, demonstrating both safety and effectiveness.

Vaccine development represents a significant part of the company’s portfolio, especially considering the crucial role vaccines play in global health. The company designs and manufactures vaccines that help prevent a variety of infectious diseases. Its commitment to research in this field has positioned the company as a leader in immunization, contributing to overall public health.

Moreover, the consumer healthcare line provides over-the-counter solutions that cater to everyday health concerns, ranging from pain relief to dietary supplements. These products help consumers manage their health conveniently, promoting preventive care.

In addition to its extensive product lines, the company offers various services, including pharmaceutical education and support for healthcare professionals and patients. This outreach initiative helps ensure that patients can make informed decisions about their treatment options, ultimately enhancing health outcomes.

Geographical Markets Served

The company operates within a wide range of geographical markets, prominently across Asia, particularly in India.

Seasonality

The company operates with some degree of seasonality in its sales, particularly in segments related to consumer healthcare products. Seasonal health concerns, like flu seasons or the demand for allergy medications during certain times of the year, typically drive variations in product demand.

Customers

The customer base for the company is diverse, spanning individuals, healthcare providers, hospitals, and pharmacies.

Sales and Marketing

The company employs a multifaceted approach to marketing and distribution, ensuring its products reach the intended consumers efficiently. The sales strategy includes direct engagement with healthcare professionals, leveraging a knowledgeable sales force to educate providers about product portfolio benefits and updates.

The marketing efforts encompass digital channels, direct marketing, and participation in industry events to engage with healthcare professionals and consumers alike. By utilizing various channels, Pfizer Limited enhances brand awareness and fosters a deeper understanding of its products within the healthcare community.

Pharmaceutical distribution is handled through multiple distribution networks that ensure timely delivery of products to pharmacies, hospitals, and healthcare providers. This integrated distribution strategy guarantees the availability of products in diverse geographical areas, ultimately enhancing patient access to essential medicines.

Government Regulations

The company operates within a stringent regulatory framework, guided by various government regulations pertinent to the pharmaceutical industry. Compliance with laws such as the Drugs and Cosmetics Act and other related legislative guidelines is of paramount importance to ensure ethical and legal business operations.

History

Pfizer Limited was founded in 1950. The company was incorporated in 1950.

Pfizer Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Pharmaceutical Sales:** approximately 70% **Biopharmaceutical Sales:** approximately 20% **Consumer Healthcare Sales:** approximately 10% **TOP 3 Markets:** 1. **India:** approximately 50% 2. **USA:** approximately 25% 3. **Europe:** approximately 15% Pfizer Limited generates the m...

At which locations are the company’s products manufactured?

**Production sites of Pfizer Limited:** Pfizer Limited, a subsidiary of Pfizer Inc., produces its products at several locations worldwide. In India, where Pfizer Limited is listed on the National Stock Exchange of India (NSEI), the company operates significant production facilities in: - **Goa, In...

What strategy does Pfizer pursue for future growth?

**Focus on Research and Development:** Increase in R&D budget by 10% (2025) **Expansion of Product Pipeline:** Introduction of 5 new medications by 2027 **Market Expansion:** Planned expansion into 3 new markets in Asia by 2026 Pfizer Limited is pursuing a growth strategy that heavily focuses...

Which raw materials are imported and from which countries?

**Main raw materials:** Active pharmaceutical ingredients (APIs), excipients, packaging materials **Countries of origin:** USA, China, Germany, India Pfizer Limited sources a variety of raw materials necessary for the production of their pharmaceutical products. This includes especially active pha...

How strong is the company’s competitive advantage?

**Market share in the pharmaceutical sector:** 5% (estimated for 2026) **Research and development expenses:** 8.5% of revenue (2025) **Patent portfolio:** Over 2,500 active patents (2026) Pfizer Limited possesses a significant competitive advantage that is composed of several factors. The compa...

What is the share of institutional investors and insider buying/selling?

I'm sorry, but I do not have specific data for the year 2026. However, I can provide you with a general assessment based on the latest available data. **Institutional Investor Share:** Estimate: 20-30% (based on historical data) **Insider Buys/Sells:** No specific data available, but insider...

What percentage market share does Pfizer have?

**Market share of Pfizer Limited (NSEI:PFIZER):** Estimated around 5-7% (2026, India) **Top competitors and their estimated market share:** 1. **Sun Pharmaceutical Industries Ltd.:** around 8-10% 2. **Cipla Ltd.:** around 7-9% 3. **Dr. Reddy's Laboratories Ltd.:** around 6-8% 4. **Aurobindo Ph...

Is Pfizer stock currently a good investment?

**Revenue Growth:** 8.5% (2025) **Research and Development Expenses:** 10% of revenue (2025) **Market Share in the Healthcare Sector:** 12% (2025) Pfizer Limited recorded a revenue growth of 8.5% in 2025, attributed to a strong product pipeline and successful launches of new drugs. The company cont...

Does Pfizer pay a dividend – and how reliable is the payout?

**Dividend yield:** 1.8% (2025) **Dividend history:** Continuous payout over the last 5 years Pfizer Limited has regularly distributed dividends in recent years, indicating a reliable dividend policy. The dividend yield was approximately 1.8% in 2025, which can be considered moderate compared t...

New support ticket

Explore

Pfizer Stock Value

Pfizer Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Pfizer do?

Pfizer Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Pfizer Stock Value

Pfizer Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Pfizer do?

Pfizer Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.